… The following factors were associated with longer overall survival: TTFields plus temozolomide
treatment (HR, 0.63; 95% CI, 0.53-0.76; P < .001), female sex (HR, 0.76, 95% CI, 0.63-…

… The median follow-up after the end of treatment was 16 months (0–72). Overall survival was
… (0–57) after the end of TMZ treatment, five in whom TMZ was reinitiated without success. …

… temozolomide alone had a median progression-free survival of … TTFields plus temozolomide
had a median overall survival of … months in those who received temozolomide alone (as per …

… Despite maximal safe surgical debulking and radiation treatment, overall survival (OS) for
the average patient remains poor.1-5 Several chemotherapeutic agents, most notably the …

… efficacy for response rates and overall survival; however, no … -agent temozolomide with
temozolomide combined with … the combination treatment arm, but no difference in overall survival …

… overall survival of patients confirmed to be treated with … survival in the second period (log-rank
P < 0.0001). Table 2 contains median survival, 24-month survival, and 36-month survival …

… significant increase in overall survival when compared with no treatment in this study. In a
… , a gain in overall survival with use of bevacizumab compared with use of other treatment for …

… all patients were treated with temozolomide. We focused on overall survival only, so are
unable to draw conclusions about using techniques to predict progression-free survival. The …

… and temozolomide (RT + TMZ) in newly diagnosed glioblastoma using overall survival as the
… Organization for Research and Treatment of Cancer (EORTC) survival data that resulted in …

… This study indicates that the addition of TMZ to radiotherapy improves overall survival by
2.5 months, a modest and incremental improvement. Importantly, in a separate analysis of all …